| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 4.47e-09 | 14 | 96 | 5 | GO:0005130 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 1.27e-08 | 34 | 96 | 6 | GO:0015125 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 7.26e-08 | 23 | 96 | 5 | GO:0034235 | |
| GeneOntologyMolecularFunction | filamin binding | 2.51e-07 | 29 | 96 | 5 | GO:0031005 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 2.51e-07 | 29 | 96 | 5 | GO:0035325 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 2.57e-07 | 90 | 96 | 7 | GO:0008028 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 4.37e-07 | 196 | 96 | 9 | GO:0005319 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 6.91e-07 | 207 | 96 | 9 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 7.20e-07 | 208 | 96 | 9 | GO:0005342 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 1.08e-06 | 70 | 96 | 6 | GO:1901618 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 1.38e-06 | 73 | 96 | 6 | GO:0170055 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLCO1B7 SLC6A12 SLC36A1 PSG2 PSG5 PSG6 PSG11 SLC6A20 ABCC5 PSG8 | 1.47e-06 | 293 | 96 | 10 | GO:0008514 |
| GeneOntologyMolecularFunction | glycolipid binding | 3.73e-06 | 49 | 96 | 5 | GO:0051861 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 7.65e-06 | 149 | 96 | 7 | GO:1990782 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor | 2.29e-05 | 2 | 96 | 2 | GO:0016639 | |
| GeneOntologyMolecularFunction | glutamate dehydrogenase [NAD(P)+] activity | 2.29e-05 | 2 | 96 | 2 | GO:0004353 | |
| GeneOntologyMolecularFunction | glutamate dehydrogenase (NAD+) activity | 2.29e-05 | 2 | 96 | 2 | GO:0004352 | |
| GeneOntologyMolecularFunction | glutamate dehydrogenase (NADP+) activity | 2.29e-05 | 2 | 96 | 2 | GO:0004354 | |
| GeneOntologyMolecularFunction | transporter activity | SLCO1B7 SLC6A12 SLC36A1 CHRNA9 ABCA5 PSG2 PSG5 PSG6 PSG11 SLC6A20 SCN10A ABCC5 ABCC9 ATP11A APOB PSG8 PKDREJ VDAC3 | 3.72e-05 | 1289 | 96 | 18 | GO:0005215 |
| GeneOntologyMolecularFunction | protein phosphatase binding | 6.95e-05 | 210 | 96 | 7 | GO:0019903 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLCO1B7 SLC6A12 SLC36A1 CHRNA9 ABCA5 PSG2 PSG5 PSG6 PSG11 SLC6A20 SCN10A ABCC5 ABCC9 PSG8 PKDREJ VDAC3 | 1.50e-04 | 1180 | 96 | 16 | GO:0022857 |
| GeneOntologyMolecularFunction | phosphatase binding | 2.86e-04 | 264 | 96 | 7 | GO:0019902 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 3.59e-04 | 29 | 96 | 3 | GO:0005416 | |
| GeneOntologyMolecularFunction | L-proline transmembrane transporter activity | 4.73e-04 | 7 | 96 | 2 | GO:0015193 | |
| GeneOntologyMolecularFunction | L-leucine binding | 4.73e-04 | 7 | 96 | 2 | GO:0070728 | |
| GeneOntologyMolecularFunction | calmodulin binding | 8.56e-04 | 230 | 96 | 6 | GO:0005516 | |
| GeneOntologyMolecularFunction | ATPase-coupled inorganic anion transmembrane transporter activity | 1.00e-03 | 10 | 96 | 2 | GO:0043225 | |
| GeneOntologyMolecularFunction | growth factor receptor binding | 1.49e-03 | 173 | 96 | 5 | GO:0070851 | |
| GeneOntologyMolecularFunction | ADP binding | 1.59e-03 | 48 | 96 | 3 | GO:0043531 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 1.69e-03 | 49 | 96 | 3 | GO:0140359 | |
| GeneOntologyMolecularFunction | GTPase binding | 1.76e-03 | 360 | 96 | 7 | GO:0051020 | |
| GeneOntologyMolecularFunction | protein homodimerization activity | EPRS1 PSG2 PSG5 PSG6 PSG11 GLUD1 GLUD2 ALS2 PSG8 HIF1AN YARS2 | 1.83e-03 | 815 | 96 | 11 | GO:0042803 |
| GeneOntologyMolecularFunction | oligopeptide transmembrane transporter activity | 2.63e-03 | 16 | 96 | 2 | GO:0035673 | |
| GeneOntologyMolecularFunction | protein kinase binding | FOXO3 EGFR PSG2 PSG5 PSG6 PSG7 PSG11 TRIM77 PSG8 NR3C1 BECN1 | 3.12e-03 | 873 | 96 | 11 | GO:0019901 |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 1.02e-09 | 24 | 95 | 6 | GO:2001214 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 3.55e-09 | 29 | 95 | 6 | GO:2001212 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 3.61e-09 | 14 | 95 | 5 | GO:0070348 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 5.40e-09 | 15 | 95 | 5 | GO:0070347 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 5.40e-09 | 15 | 95 | 5 | GO:1903387 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 5.40e-09 | 15 | 95 | 5 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 5.40e-09 | 15 | 95 | 5 | GO:0002859 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 5.46e-09 | 31 | 95 | 6 | GO:0010544 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 7.82e-09 | 16 | 95 | 5 | GO:0038016 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 9.86e-09 | 34 | 95 | 6 | GO:0043116 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 1.10e-08 | 17 | 95 | 5 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 1.10e-08 | 17 | 95 | 5 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 1.10e-08 | 17 | 95 | 5 | GO:0038158 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 1.19e-08 | 35 | 95 | 6 | GO:1901142 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 1.52e-08 | 18 | 95 | 5 | GO:1903385 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 2.74e-08 | 20 | 95 | 5 | GO:2000346 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 3.58e-08 | 21 | 95 | 5 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 3.58e-08 | 21 | 95 | 5 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 3.58e-08 | 21 | 95 | 5 | GO:0002838 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 4.61e-08 | 22 | 95 | 5 | GO:0030853 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | SLCO1B7 EPRS1 SLC6A12 CROT SLC36A1 PSG2 PSG5 PSG6 PSG11 SLC6A20 ABCC5 PSG8 NR3C1 | 4.99e-08 | 410 | 95 | 13 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | SLCO1B7 EPRS1 SLC6A12 CROT SLC36A1 PSG2 PSG5 PSG6 PSG11 SLC6A20 ABCC5 PSG8 NR3C1 | 5.29e-08 | 412 | 95 | 13 | GO:0015849 |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 5.87e-08 | 23 | 95 | 5 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 5.87e-08 | 23 | 95 | 5 | GO:0002858 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 7.39e-08 | 24 | 95 | 5 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 7.39e-08 | 24 | 95 | 5 | GO:0002420 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 7.50e-08 | 47 | 95 | 6 | GO:0015721 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 9.20e-08 | 25 | 95 | 5 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 9.20e-08 | 25 | 95 | 5 | GO:0002423 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 1.39e-07 | 27 | 95 | 5 | GO:0070344 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 1.68e-07 | 28 | 95 | 5 | GO:0034111 | |
| GeneOntologyBiologicalProcess | regulation of ERBB signaling pathway | 2.41e-07 | 93 | 95 | 7 | GO:1901184 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 3.40e-07 | 32 | 95 | 5 | GO:0045779 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 3.40e-07 | 32 | 95 | 5 | GO:0070341 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 3.40e-07 | 32 | 95 | 5 | GO:0060312 | |
| GeneOntologyBiologicalProcess | negative regulation of wound healing | 3.46e-07 | 98 | 95 | 7 | GO:0061045 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 3.99e-07 | 33 | 95 | 5 | GO:0030852 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 3.99e-07 | 33 | 95 | 5 | GO:2000252 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 4.67e-07 | 34 | 95 | 5 | GO:0046851 | |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 5.92e-07 | 66 | 95 | 6 | GO:0010543 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid transport | 6.15e-07 | 213 | 95 | 9 | GO:0015718 | |
| GeneOntologyBiologicalProcess | organic anion transport | SLCO1B7 EPRS1 SLC6A12 CROT SLC36A1 PSG2 PSG5 PSG6 PSG11 SLC6A20 ABCC5 PSG8 NR3C1 | 6.80e-07 | 515 | 95 | 13 | GO:0015711 |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 7.72e-07 | 69 | 95 | 6 | GO:0030195 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 8.29e-07 | 38 | 95 | 5 | GO:2000345 | |
| GeneOntologyBiologicalProcess | regulation of bone resorption | 8.41e-07 | 70 | 95 | 6 | GO:0045124 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 8.41e-07 | 70 | 95 | 6 | GO:1900047 | |
| GeneOntologyBiologicalProcess | regulation of vascular permeability | 9.16e-07 | 71 | 95 | 6 | GO:0043114 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 9.48e-07 | 39 | 95 | 5 | GO:0045717 | |
| GeneOntologyBiologicalProcess | negative regulation of coagulation | 9.95e-07 | 72 | 95 | 6 | GO:0050819 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 1.08e-06 | 40 | 95 | 5 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 1.22e-06 | 41 | 95 | 5 | GO:0002716 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 1.37e-06 | 76 | 95 | 6 | GO:0042269 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 1.39e-06 | 42 | 95 | 5 | GO:0090330 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 1.86e-06 | 80 | 95 | 6 | GO:0002715 | |
| GeneOntologyBiologicalProcess | regulation of bone remodeling | 1.86e-06 | 80 | 95 | 6 | GO:0046850 | |
| GeneOntologyBiologicalProcess | response to aluminum ion | 1.87e-06 | 6 | 95 | 3 | GO:0010044 | |
| GeneOntologyBiologicalProcess | negative regulation of response to wounding | 1.90e-06 | 126 | 95 | 7 | GO:1903035 | |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 1.97e-06 | 45 | 95 | 5 | GO:0048521 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 2.20e-06 | 46 | 95 | 5 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 2.20e-06 | 46 | 95 | 5 | GO:0072574 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 2.45e-06 | 47 | 95 | 5 | GO:0001911 | |
| GeneOntologyBiologicalProcess | negative regulation of tissue remodeling | 2.45e-06 | 47 | 95 | 5 | GO:0034104 | |
| GeneOntologyBiologicalProcess | regulation of sprouting angiogenesis | 2.66e-06 | 85 | 95 | 6 | GO:1903670 | |
| GeneOntologyBiologicalProcess | regulation of epidermal growth factor receptor signaling pathway | 2.84e-06 | 86 | 95 | 6 | GO:0042058 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 3.03e-06 | 49 | 95 | 5 | GO:0072576 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 3.03e-06 | 49 | 95 | 5 | GO:0002837 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 3.35e-06 | 50 | 95 | 5 | GO:0002834 | |
| GeneOntologyBiologicalProcess | regulation of blood coagulation | 3.96e-06 | 91 | 95 | 6 | GO:0030193 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 4.08e-06 | 52 | 95 | 5 | GO:0031342 | |
| GeneOntologyBiologicalProcess | vascular process in circulatory system | 4.21e-06 | 344 | 95 | 10 | GO:0003018 | |
| GeneOntologyBiologicalProcess | regulation of homotypic cell-cell adhesion | 4.49e-06 | 53 | 95 | 5 | GO:0034110 | |
| GeneOntologyBiologicalProcess | regulation of hemostasis | 4.49e-06 | 93 | 95 | 6 | GO:1900046 | |
| GeneOntologyBiologicalProcess | regulation of coagulation | 5.40e-06 | 96 | 95 | 6 | GO:0050818 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 5.91e-06 | 56 | 95 | 5 | GO:0002418 | |
| GeneOntologyBiologicalProcess | bone resorption | 6.46e-06 | 99 | 95 | 6 | GO:0045453 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 7.67e-06 | 59 | 95 | 5 | GO:0045671 | |
| GeneOntologyBiologicalProcess | granulocyte differentiation | 8.33e-06 | 60 | 95 | 5 | GO:0030851 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid metabolic process | 8.33e-06 | 60 | 95 | 5 | GO:0045922 | |
| GeneOntologyBiologicalProcess | carboxylic acid biosynthetic process | 8.76e-06 | 374 | 95 | 10 | GO:0046394 | |
| GeneOntologyBiologicalProcess | regulation of feeding behavior | 9.04e-06 | 61 | 95 | 5 | GO:0060259 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity | 9.07e-06 | 105 | 95 | 6 | GO:0042267 | |
| GeneOntologyBiologicalProcess | ERBB signaling pathway | 9.24e-06 | 160 | 95 | 7 | GO:0038127 | |
| GeneOntologyBiologicalProcess | organic acid biosynthetic process | 9.39e-06 | 377 | 95 | 10 | GO:0016053 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immunity | 1.13e-05 | 109 | 95 | 6 | GO:0002228 | |
| GeneOntologyBiologicalProcess | regulation of wound healing | 1.17e-05 | 166 | 95 | 7 | GO:0061041 | |
| GeneOntologyBiologicalProcess | small molecule biosynthetic process | PECR MSMO1 PSG2 PSG5 PSG6 PSG11 GLUD1 GLUD2 APOB PSG8 FGFR4 NR3C1 UROS | 1.32e-05 | 676 | 95 | 13 | GO:0044283 |
| GeneOntologyBiologicalProcess | regulation of endothelial cell differentiation | 1.44e-05 | 67 | 95 | 5 | GO:0045601 | |
| GeneOntologyBiologicalProcess | negative regulation of innate immune response | 1.45e-05 | 114 | 95 | 6 | GO:0045824 | |
| GeneOntologyBiologicalProcess | vasculogenesis | 1.77e-05 | 118 | 95 | 6 | GO:0001570 | |
| GeneOntologyBiologicalProcess | regulation of lipid biosynthetic process | 1.82e-05 | 246 | 95 | 8 | GO:0046890 | |
| GeneOntologyBiologicalProcess | gland morphogenesis | 1.85e-05 | 178 | 95 | 7 | GO:0022612 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 1.91e-05 | 71 | 95 | 5 | GO:0002347 | |
| GeneOntologyBiologicalProcess | negative regulation of interleukin-1 production | 2.04e-05 | 72 | 95 | 5 | GO:0032692 | |
| GeneOntologyBiologicalProcess | lipid biosynthetic process | PIGB PECR SCCPDH MSMO1 PSG2 PSG5 PSG6 PSG11 GCDH APOB PSG8 FGFR4 NR3C1 BECN1 | 2.06e-05 | 813 | 95 | 14 | GO:0008610 |
| GeneOntologyBiologicalProcess | lipid transport | SLCO1B7 EPRS1 CROT ABCA5 PSG2 PSG5 PSG6 PSG11 ATP11A APOB PSG8 | 2.12e-05 | 506 | 95 | 11 | GO:0006869 |
| GeneOntologyBiologicalProcess | regulation of fatty acid biosynthetic process | 2.19e-05 | 73 | 95 | 5 | GO:0042304 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated cytotoxicity | 2.35e-05 | 124 | 95 | 6 | GO:0001910 | |
| GeneOntologyBiologicalProcess | bone remodeling | 2.69e-05 | 127 | 95 | 6 | GO:0046849 | |
| GeneOntologyBiologicalProcess | regulation of tissue remodeling | 2.81e-05 | 128 | 95 | 6 | GO:0034103 | |
| GeneOntologyBiologicalProcess | positive regulation of MAP kinase activity | 2.94e-05 | 129 | 95 | 6 | GO:0043406 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 7.72e-09 | 16 | 96 | 5 | GO:0070021 | |
| GeneOntologyCellularComponent | basal part of cell | SLCO1B7 SLC6A12 CLASP1 EGFR PSG2 PSG5 PSG6 PSG11 PTPRQ ABCC5 PSG8 | 1.30e-06 | 378 | 96 | 11 | GO:0045178 |
| GeneOntologyCellularComponent | basal plasma membrane | 5.30e-06 | 354 | 96 | 10 | GO:0009925 | |
| GeneOntologyCellularComponent | receptor complex | PTPRB CHRNA9 EGFR PSG2 PSG5 PSG6 ITLN1 PSG11 PTPRQ PSG8 FGFR4 IL18RAP | 1.41e-05 | 581 | 96 | 12 | GO:0043235 |
| GeneOntologyCellularComponent | apical plasma membrane | SLC36A1 EGFR PSG2 MUC17 PSG5 PSG6 PSG11 PTPRQ SLC6A20 ABCC5 PSG8 | 1.45e-05 | 487 | 96 | 11 | GO:0016324 |
| GeneOntologyCellularComponent | basolateral plasma membrane | 1.66e-05 | 320 | 96 | 9 | GO:0016323 | |
| GeneOntologyCellularComponent | apical part of cell | SLC36A1 EGFR PSG2 MUC17 PSG5 PSG6 PSG11 PTPRQ SLC6A20 ABCC5 PSG8 DUOXA2 | 1.70e-05 | 592 | 96 | 12 | GO:0045177 |
| GeneOntologyCellularComponent | cell projection membrane | 2.91e-05 | 431 | 96 | 10 | GO:0031253 | |
| GeneOntologyCellularComponent | lateral plasma membrane | 5.94e-05 | 90 | 96 | 5 | GO:0016328 | |
| GeneOntologyCellularComponent | ciliary membrane | 8.91e-05 | 98 | 96 | 5 | GO:0060170 | |
| GeneOntologyCellularComponent | adherens junction | 4.40e-04 | 212 | 96 | 6 | GO:0005912 | |
| GeneOntologyCellularComponent | intraciliary transport particle A | 5.74e-04 | 8 | 96 | 2 | GO:0030991 | |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 7.91e-04 | 157 | 96 | 5 | GO:1902554 | |
| GeneOntologyCellularComponent | T cell receptor complex | 9.36e-04 | 163 | 96 | 5 | GO:0042101 | |
| GeneOntologyCellularComponent | protein kinase complex | 1.13e-03 | 170 | 96 | 5 | GO:1902911 | |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | 1.16e-03 | 350 | 96 | 7 | GO:0098802 | |
| GeneOntologyCellularComponent | photoreceptor connecting cilium | 1.40e-03 | 48 | 96 | 3 | GO:0032391 | |
| GeneOntologyCellularComponent | early endosome | 1.68e-03 | 481 | 96 | 8 | GO:0005769 | |
| GeneOntologyCellularComponent | endosome membrane | 1.80e-03 | 602 | 96 | 9 | GO:0010008 | |
| GeneOntologyCellularComponent | endosome | SORT1 ANTXR2 EGFR ABCA5 ABCC5 ALS2 ATP11A APOB FGFR4 PLA2G4E WLS RAB29 BECN1 | 2.59e-03 | 1167 | 96 | 13 | GO:0005768 |
| GeneOntologyCellularComponent | external side of plasma membrane | 2.69e-03 | 519 | 96 | 8 | GO:0009897 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 3.23e-03 | 785 | 96 | 10 | GO:0098797 | |
| MousePheno | abnormal skeletal muscle cell glucose uptake | 5.60e-09 | 47 | 76 | 7 | MP:0031617 | |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 2.44e-08 | 17 | 76 | 5 | MP:0031047 | |
| MousePheno | decreased skeletal muscle cell glucose uptake | 3.03e-08 | 35 | 76 | 6 | MP:0031618 | |
| MousePheno | decreased muscle cell glucose uptake | 5.98e-08 | 39 | 76 | 6 | MP:0030022 | |
| MousePheno | abnormal muscle cell glucose uptake | 7.10e-08 | 67 | 76 | 7 | MP:0004130 | |
| MousePheno | abnormal carbon dioxide production | 7.10e-08 | 67 | 76 | 7 | MP:0008962 | |
| MousePheno | increased skeletal muscle triglyceride level | 7.90e-08 | 21 | 76 | 5 | MP:0031415 | |
| MousePheno | decreased fatty acid oxidation | 1.63e-07 | 24 | 76 | 5 | MP:0014172 | |
| MousePheno | abnormal susceptibility to Coronaviridae infection | 2.45e-07 | 49 | 76 | 6 | MP:0020948 | |
| MousePheno | increased abdominal fat pad weight | 3.06e-07 | 27 | 76 | 5 | MP:0009286 | |
| MousePheno | abnormal insulin secretion | 3.51e-07 | 171 | 76 | 9 | MP:0003564 | |
| MousePheno | decreased susceptibility to Coronaviridae infection | 3.71e-07 | 28 | 76 | 5 | MP:0020950 | |
| MousePheno | decreased cellular glucose uptake | 3.96e-07 | 53 | 76 | 6 | MP:0003926 | |
| MousePheno | abnormal fatty acid oxidation | 4.44e-07 | 54 | 76 | 6 | MP:0010953 | |
| MousePheno | abnormal endocrine pancreas secretion | 4.47e-07 | 176 | 76 | 9 | MP:0014195 | |
| MousePheno | abnormal pancreas secretion | 6.21e-07 | 183 | 76 | 9 | MP:0002694 | |
| MousePheno | abnormal skeletal muscle triglyceride level | 6.32e-07 | 31 | 76 | 5 | MP:0031413 | |
| MousePheno | decreased carbon dioxide production | 6.32e-07 | 31 | 76 | 5 | MP:0008964 | |
| MousePheno | abnormal lipid oxidation | 9.26e-07 | 61 | 76 | 6 | MP:0010951 | |
| MousePheno | abnormal pancreatic beta cell physiology | 1.10e-06 | 196 | 76 | 9 | MP:0003562 | |
| MousePheno | abnormal cellular glucose uptake | 1.29e-06 | 102 | 76 | 7 | MP:0003925 | |
| MousePheno | abnormal muscle triglyceride level | 1.37e-06 | 36 | 76 | 5 | MP:0031412 | |
| MousePheno | abnormal endocrine pancreas physiology | 1.42e-06 | 202 | 76 | 9 | MP:0010147 | |
| MousePheno | decreased susceptibility to Riboviria infection induced morbidity/mortality | 3.83e-06 | 44 | 76 | 5 | MP:0031023 | |
| MousePheno | abnormal endocrine gland physiology | PCSK2 ABCA5 PSG2 PSG5 PSG6 PSG11 GLUD1 GLUD2 PSG8 NR3C1 RIMS2 | 3.93e-06 | 363 | 76 | 11 | MP:0013561 |
| MousePheno | decreased susceptibility to viral infection induced morbidity/mortality | 1.80e-05 | 60 | 76 | 5 | MP:0009790 | |
| MousePheno | increased insulin secretion | 2.47e-05 | 64 | 76 | 5 | MP:0003058 | |
| MousePheno | abnormal pancreas physiology | 2.80e-05 | 292 | 76 | 9 | MP:0002693 | |
| MousePheno | abnormal branching involved in lung morphogenesis | 3.31e-05 | 34 | 76 | 4 | MP:0011024 | |
| MousePheno | obese | 3.37e-05 | 113 | 76 | 6 | MP:0001261 | |
| MousePheno | abnormal vascular wound healing | 4.68e-05 | 73 | 76 | 5 | MP:0004883 | |
| MousePheno | decreased susceptibility to infection induced morbidity/mortality | 4.73e-05 | 120 | 76 | 6 | MP:0009786 | |
| MousePheno | impaired glucose tolerance | PPP1R3A FOXO3 PCSK2 EPRS1 PSG2 PSG5 PSG6 PSG11 ABCC5 PSG8 RIMS2 | 5.32e-05 | 480 | 76 | 11 | MP:0005293 |
| MousePheno | decreased oxygen consumption | 6.85e-05 | 79 | 76 | 5 | MP:0005290 | |
| MousePheno | abnormal muscle morphology | WDR19 PPP1R3A ZNF106 PTPRB EGFR ABCA5 PSG2 PSG5 PSG6 PSG11 MYO18A ABCC9 ALS2 ATP11A PSG8 HIF1AN VDAC3 | 7.18e-05 | 1106 | 76 | 17 | MP:0002108 |
| MousePheno | polyphagia | 7.27e-05 | 80 | 76 | 5 | MP:0001433 | |
| MousePheno | abnormal gland physiology | FOXO3 PCSK2 EGFR ABCA5 PSG2 PSG5 PSG6 PSG11 GLUD1 GLUD2 PSG8 NR3C1 RIMS2 | 8.04e-05 | 691 | 76 | 13 | MP:0002164 |
| MousePheno | decreased susceptibility to Riboviria infection | 8.19e-05 | 82 | 76 | 5 | MP:0020914 | |
| MousePheno | abnormal oxygen consumption | 8.95e-05 | 195 | 76 | 7 | MP:0005288 | |
| MousePheno | abnormal glycogen homeostasis | 1.30e-04 | 144 | 76 | 6 | MP:0005438 | |
| MousePheno | abnormal colon morphology | 1.75e-04 | 152 | 76 | 6 | MP:0000495 | |
| MousePheno | abnormal glucose tolerance | PPP1R3A FOXO3 PCSK2 EPRS1 PSG2 PSG5 PSG6 PSG11 ABCC5 ABCC9 PSG8 RIMS2 DUOXA2 | 2.92e-04 | 787 | 76 | 13 | MP:0005291 |
| MousePheno | decreased respiratory quotient | 3.26e-04 | 110 | 76 | 5 | MP:0010379 | |
| MousePheno | abnormal skeletal muscle morphology | 4.07e-04 | 508 | 76 | 10 | MP:0000759 | |
| MousePheno | decreased energy expenditure | 4.69e-04 | 119 | 76 | 5 | MP:0004890 | |
| MousePheno | increased total body fat amount | 4.70e-04 | 424 | 76 | 9 | MP:0010024 | |
| MousePheno | abnormal susceptibility to Riboviria infection | 5.17e-04 | 186 | 76 | 6 | MP:0020912 | |
| MousePheno | increased food intake | 5.63e-04 | 189 | 76 | 6 | MP:0011939 | |
| MousePheno | increased circulating leptin level | 5.87e-04 | 125 | 76 | 5 | MP:0005669 | |
| MousePheno | decreased susceptibility to viral infection | 5.87e-04 | 125 | 76 | 5 | MP:0002410 | |
| MousePheno | increased lean body mass | 6.58e-04 | 354 | 76 | 8 | MP:0003960 | |
| MousePheno | insulin resistance | 7.00e-04 | 197 | 76 | 6 | MP:0005331 | |
| MousePheno | decreased circulating triglyceride level | 7.26e-04 | 275 | 76 | 7 | MP:0002644 | |
| MousePheno | abnormal susceptibility to infection induced morbidity/mortality | 7.90e-04 | 279 | 76 | 7 | MP:0009785 | |
| MousePheno | abnormal physiological response to xenobiotic | SLCO1B7 FOXO3 PSG2 PSG5 PSG6 PSG11 ABCC9 ALS2 PSG8 IFT122 NR3C1 | 8.55e-04 | 662 | 76 | 11 | MP:0008872 |
| MousePheno | increased circulating insulin level | 8.59e-04 | 283 | 76 | 7 | MP:0002079 | |
| MousePheno | increased incidence of tumors by chemical induction | 1.01e-03 | 141 | 76 | 5 | MP:0004499 | |
| MousePheno | increased circulating hormone level | 1.10e-03 | 578 | 76 | 10 | MP:0014456 | |
| MousePheno | abnormal terminal bronchiole morphology | 1.28e-03 | 10 | 76 | 2 | MP:0002268 | |
| MousePheno | abnormal blood vessel physiology | 1.31e-03 | 394 | 76 | 8 | MP:0000249 | |
| Domain | Ig_2 | 7.53e-08 | 73 | 93 | 7 | PF13895 | |
| Domain | ELFV_dehydrog_N | 2.45e-05 | 2 | 93 | 2 | PF02812 | |
| Domain | Glu/Leu/Phe/Val_DH_C | 2.45e-05 | 2 | 93 | 2 | IPR006096 | |
| Domain | Glu/Leu/Phe/Val_DH_dimer_dom | 2.45e-05 | 2 | 93 | 2 | IPR006097 | |
| Domain | Glu/Leu/Phe/Val_DH | 2.45e-05 | 2 | 93 | 2 | IPR006095 | |
| Domain | ELFV_dehydrog | 2.45e-05 | 2 | 93 | 2 | PF00208 | |
| Domain | ELFV_dehydrog | 2.45e-05 | 2 | 93 | 2 | SM00839 | |
| Domain | Glu/Leu/Phe/Val_DH_AS | 2.45e-05 | 2 | 93 | 2 | IPR033524 | |
| Domain | DuoxA | 2.45e-05 | 2 | 93 | 2 | PF10204 | |
| Domain | Dual_oxidase_maturation_fac | 2.45e-05 | 2 | 93 | 2 | IPR018469 | |
| Domain | NAD_bind_Glu_DH | 2.45e-05 | 2 | 93 | 2 | IPR033922 | |
| Domain | GLFV_DEHYDROGENASE | 2.45e-05 | 2 | 93 | 2 | PS00074 | |
| Domain | ig | 4.57e-05 | 190 | 93 | 7 | PF00047 | |
| Domain | Immunoglobulin | 4.57e-05 | 190 | 93 | 7 | IPR013151 | |
| Domain | IGc2 | 1.73e-04 | 235 | 93 | 7 | SM00408 | |
| Domain | Ig_sub2 | 1.73e-04 | 235 | 93 | 7 | IPR003598 | |
| Domain | V-set | 3.16e-04 | 184 | 93 | 6 | PF07686 | |
| Domain | Ig_V-set | 4.79e-04 | 199 | 93 | 6 | IPR013106 | |
| Domain | - | 5.90e-04 | 207 | 93 | 6 | 1.25.40.10 | |
| Domain | TPR-like_helical_dom | 1.09e-03 | 233 | 93 | 6 | IPR011990 | |
| Domain | ABC_transporter_CS | 1.19e-03 | 42 | 93 | 3 | IPR017871 | |
| Domain | IG | 1.19e-03 | 421 | 93 | 8 | SM00409 | |
| Domain | Ig_sub | 1.19e-03 | 421 | 93 | 8 | IPR003599 | |
| Domain | - | 1.37e-03 | 333 | 93 | 7 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 1.42e-03 | 335 | 93 | 7 | IPR015943 | |
| Domain | - | 1.69e-03 | 663 | 93 | 10 | 2.60.40.10 | |
| Domain | ABC_tran | 1.76e-03 | 48 | 93 | 3 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 1.76e-03 | 48 | 93 | 3 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 1.87e-03 | 49 | 93 | 3 | PS00211 | |
| Domain | ABC_transporter-like | 1.98e-03 | 50 | 93 | 3 | IPR003439 | |
| Domain | Ig-like_fold | 2.68e-03 | 706 | 93 | 10 | IPR013783 | |
| Domain | IG_LIKE | 3.11e-03 | 491 | 93 | 8 | PS50835 | |
| Domain | aa-tRNA-synth_I_CS | 3.56e-03 | 18 | 93 | 2 | IPR001412 | |
| Domain | LH2 | 3.56e-03 | 18 | 93 | 2 | SM00308 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 3.56e-03 | 18 | 93 | 2 | PS00754 | |
| Domain | Ig-like_dom | 3.60e-03 | 503 | 93 | 8 | IPR007110 | |
| Domain | SNF | 3.97e-03 | 19 | 93 | 2 | PF00209 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 3.97e-03 | 19 | 93 | 2 | PS00610 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 3.97e-03 | 19 | 93 | 2 | PS50267 | |
| Domain | Na/ntran_symport | 3.97e-03 | 19 | 93 | 2 | IPR000175 | |
| Domain | AA_TRNA_LIGASE_I | 3.97e-03 | 19 | 93 | 2 | PS00178 | |
| Domain | PLAT | 4.84e-03 | 21 | 93 | 2 | PS50095 | |
| Domain | - | 4.84e-03 | 21 | 93 | 2 | 2.60.60.20 | |
| Domain | PLAT | 4.84e-03 | 21 | 93 | 2 | PF01477 | |
| Domain | PLAT/LH2_dom | 4.84e-03 | 21 | 93 | 2 | IPR001024 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 9.43e-06 | 194 | 76 | 8 | M16312 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS | 1.51e-05 | 99 | 76 | 6 | MM14624 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 2.22e-05 | 158 | 76 | 7 | MM14812 | |
| Pathway | WP_EGFR1_SIGNALING_PATHWAY | 6.75e-05 | 188 | 76 | 7 | MM15828 | |
| Pubmed | CEACAM1 modulates epidermal growth factor receptor--mediated cell proliferation. | 1.85e-12 | 15 | 96 | 6 | 15467833 | |
| Pubmed | 8.02e-12 | 8 | 96 | 5 | 1690992 | ||
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 1.82e-10 | 13 | 96 | 5 | 1985902 | |
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 1.82e-10 | 13 | 96 | 5 | 19273835 | |
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 1.82e-10 | 13 | 96 | 5 | 16638824 | |
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 20044046 | ||
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 32150576 | ||
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 6265583 | ||
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 34440862 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 1.82e-10 | 13 | 96 | 5 | 12832451 | |
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 25406283 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 1.82e-10 | 13 | 96 | 5 | 21670291 | |
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 22162753 | ||
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 2702644 | ||
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 8380065 | ||
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 1279194 | ||
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 25724769 | ||
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 26374765 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 1.82e-10 | 13 | 96 | 5 | 22092845 | |
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 11801635 | ||
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 28913658 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 1.82e-10 | 13 | 96 | 5 | 8500759 | |
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 1.82e-10 | 13 | 96 | 5 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 1.82e-10 | 13 | 96 | 5 | 23800882 | |
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 19285068 | ||
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 21760897 | ||
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 1719235 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 1.82e-10 | 13 | 96 | 5 | 1326665 | |
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 1.82e-10 | 13 | 96 | 5 | 39168268 | |
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 8402684 | ||
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 16619040 | ||
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 1.82e-10 | 13 | 96 | 5 | 8209741 | |
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 1.82e-10 | 13 | 96 | 5 | 21949477 | |
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 26219866 | ||
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 2133556 | ||
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 32521208 | ||
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 19406938 | ||
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 19621080 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 1.82e-10 | 13 | 96 | 5 | 29967450 | |
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 1.82e-10 | 13 | 96 | 5 | 19358828 | |
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 16680193 | ||
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 1653760 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 1.82e-10 | 13 | 96 | 5 | 34058224 | |
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 10964771 | ||
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 32169849 | ||
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 22469976 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 1.82e-10 | 13 | 96 | 5 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 1.82e-10 | 13 | 96 | 5 | 28035001 | |
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 1.82e-10 | 13 | 96 | 5 | 15316023 | |
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 1.82e-10 | 13 | 96 | 5 | 23935487 | |
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 15331748 | ||
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 1.82e-10 | 13 | 96 | 5 | 22406619 | |
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 7628460 | ||
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 1.82e-10 | 13 | 96 | 5 | 25972571 | |
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 19008452 | ||
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 1.82e-10 | 13 | 96 | 5 | 15220458 | |
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 18843289 | ||
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 15207636 | ||
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 21081647 | ||
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 11133662 | ||
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 11483763 | ||
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 2164599 | ||
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 29396368 | ||
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 18003729 | ||
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 26284027 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 1.82e-10 | 13 | 96 | 5 | 33352461 | |
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 38381498 | ||
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 20739537 | ||
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 1633107 | ||
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 1.82e-10 | 13 | 96 | 5 | 27695943 | |
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 20404914 | ||
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 26911181 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 1.82e-10 | 13 | 96 | 5 | 32027621 | |
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 1.82e-10 | 13 | 96 | 5 | 27777319 | |
| Pubmed | 1.82e-10 | 13 | 96 | 5 | 18848945 | ||
| Pubmed | 2.83e-10 | 14 | 96 | 5 | 37531413 | ||
| Pubmed | Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36. | 2.83e-10 | 14 | 96 | 5 | 34666041 | |
| Pubmed | 2.83e-10 | 14 | 96 | 5 | 34619794 | ||
| Pubmed | SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms. | 2.83e-10 | 14 | 96 | 5 | 17081782 | |
| Pubmed | Loss of Ceacam1 promotes prostate cancer progression in Pten haploinsufficient male mice. | 2.83e-10 | 14 | 96 | 5 | 32209360 | |
| Pubmed | 2.83e-10 | 14 | 96 | 5 | 11994468 | ||
| Pubmed | 2.83e-10 | 14 | 96 | 5 | 11850617 | ||
| Pubmed | 2.83e-10 | 14 | 96 | 5 | 20381490 | ||
| Pubmed | CEACAM1 regulates integrin αIIbβ3-mediated functions in platelets. | 2.83e-10 | 14 | 96 | 5 | 26196244 | |
| Pubmed | 2.83e-10 | 14 | 96 | 5 | 8896983 | ||
| Pubmed | 2.83e-10 | 14 | 96 | 5 | 22962327 | ||
| Pubmed | 2.83e-10 | 14 | 96 | 5 | 17623671 | ||
| Pubmed | 2.83e-10 | 14 | 96 | 5 | 26846848 | ||
| Pubmed | CEACAM1, a SOX9 direct transcriptional target identified in the colon epithelium. | 2.83e-10 | 14 | 96 | 5 | 18794798 | |
| Pubmed | 2.83e-10 | 14 | 96 | 5 | 23469261 | ||
| Pubmed | 2.83e-10 | 14 | 96 | 5 | 18454175 | ||
| Pubmed | 2.83e-10 | 14 | 96 | 5 | 22159884 | ||
| Pubmed | 2.83e-10 | 14 | 96 | 5 | 29907459 | ||
| Pubmed | 2.83e-10 | 14 | 96 | 5 | 36719377 | ||
| Pubmed | 2.83e-10 | 14 | 96 | 5 | 23780386 | ||
| Cytoband | 19q13.2 | 2.57e-05 | 164 | 96 | 5 | 19q13.2 | |
| Cytoband | 15q15.1 | 1.34e-04 | 47 | 96 | 3 | 15q15.1 | |
| Cytoband | 20p11.2 | 2.35e-04 | 11 | 96 | 2 | 20p11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q21 | 5.38e-04 | 177 | 96 | 4 | chr15q21 | |
| Cytoband | 1q21.3 | 1.94e-03 | 117 | 96 | 3 | 1q21.3 | |
| Cytoband | 10q24 | 2.46e-03 | 35 | 96 | 2 | 10q24 | |
| Cytoband | 17q21.33 | 3.36e-03 | 41 | 96 | 2 | 17q21.33 | |
| Cytoband | 4p14 | 3.53e-03 | 42 | 96 | 2 | 4p14 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 8.54e-13 | 11 | 66 | 6 | 1315 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 3.21e-04 | 163 | 66 | 5 | 590 | |
| GeneFamily | ATP binding cassette subfamily C | 9.97e-04 | 13 | 66 | 2 | 807 | |
| GeneFamily | Aminoacyl tRNA synthetases, Class I | 2.16e-03 | 19 | 66 | 2 | 131 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 2.64e-03 | 21 | 66 | 2 | 813 | |
| GeneFamily | Intraflagellar transport proteins|Tetratricopeptide repeat domain containing | 3.44e-03 | 24 | 66 | 2 | 615 | |
| Coexpression | GIBBONS_GENETIC_MOUSE_MODEL_LUNG_ADENOCARCINOMA_DOWN_IN_METASTASIS | 1.10e-07 | 32 | 96 | 5 | MM2 | |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 1.77e-07 | 35 | 96 | 5 | MM757 | |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 3.38e-07 | 75 | 96 | 6 | MM605 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA3_DN | 8.19e-07 | 87 | 96 | 6 | MM851 | |
| Coexpression | WANG_RESPONSE_TO_BEXAROTENE_UP | 8.97e-07 | 48 | 96 | 5 | MM531 | |
| Coexpression | DESCARTES_FETAL_PLACENTA_TROPHOBLAST_GIANT_CELLS | 1.22e-06 | 93 | 96 | 6 | M40279 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_DN | 2.01e-06 | 159 | 96 | 7 | MM760 | |
| Coexpression | MARTINEZ_RB1_TARGETS_UP | ZNF106 PIGB EGFR PSG2 PSG5 UBAP2L PSG6 PSG11 ABCC5 PSG8 NR3C1 PKDREJ FRMD4B | 3.10e-06 | 741 | 96 | 13 | MM1037 |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_UP | SORT1 ZNF106 EGFR PSG2 PSG5 UBAP2L PSG6 PSG11 ABCC5 PSG8 NR3C1 PKDREJ | 8.23e-06 | 689 | 96 | 12 | MM1041 |
| Coexpression | GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_UP | 9.10e-06 | 200 | 96 | 7 | M6049 | |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_DN | 1.06e-05 | 135 | 96 | 6 | MM965 | |
| Coexpression | DESCARTES_FETAL_ADRENAL_CSH1_CSH2_POSITIVE_CELLS | 1.90e-05 | 224 | 96 | 7 | M40145 | |
| Coexpression | FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL | 2.76e-05 | 327 | 96 | 8 | M4008 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_4_5WK_UP | 8.53e-05 | 284 | 96 | 7 | MM987 | |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH1_UP | 8.83e-05 | 197 | 96 | 6 | M5378 | |
| Coexpression | GSE21063_3H_VS_16H_ANTI_IGM_STIM_BCELL_DN | 8.83e-05 | 197 | 96 | 6 | M8271 | |
| Coexpression | GSE26351_UNSTIM_VS_WNT_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN | 9.60e-05 | 200 | 96 | 6 | M8476 | |
| Coexpression | GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_IL6_TREATED_UP | 9.60e-05 | 200 | 96 | 6 | M7452 | |
| Coexpression | OHGUCHI_LIVER_HNF4A_TARGETS_DN | 9.86e-05 | 201 | 96 | 6 | MM1294 | |
| Coexpression | BROWN_MYELOID_CELL_DEVELOPMENT_UP | 9.86e-05 | 201 | 96 | 6 | MM1006 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP | 1.10e-04 | 128 | 96 | 5 | MM1000 | |
| Coexpression | ZHANG_UTERUS_C1_REGENERATIVE_UP | 1.25e-04 | 302 | 96 | 7 | MM16604 | |
| Coexpression | SWEET_LUNG_CANCER_KRAS_UP | 1.52e-04 | 534 | 96 | 9 | MM1050 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_UP | 1.85e-04 | 143 | 96 | 5 | MM989 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_3_4WK_UP | 2.05e-04 | 230 | 96 | 6 | MM986 | |
| Coexpression | MARTINEZ_TP53_TARGETS_UP | 2.31e-04 | 694 | 96 | 10 | MM1039 | |
| Coexpression | LI_CISPLATIN_RESISTANCE_DN | 2.40e-04 | 33 | 96 | 3 | M10150 | |
| Coexpression | ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_1DY_DN | 2.73e-04 | 85 | 96 | 4 | M41085 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma-6|TCGA-Cervix / Sample_Type by Project: Shred V9 | 5.06e-07 | 136 | 96 | 6 | 2c723777fadc5946df67d3e992471d8134b827f4 | |
| ToppCell | IPF-Epithelial-Mesothelial|IPF / Disease state, Lineage and Cell class | 2.59e-06 | 180 | 96 | 6 | 1fa54bf4dba72866b2295639d991af639341bc08 | |
| ToppCell | IPF-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 2.85e-06 | 183 | 96 | 6 | 7df20e3172a1220ff427f30181f4f0c3b7fe2d42 | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 2.95e-06 | 184 | 96 | 6 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | AT2_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 4.11e-06 | 195 | 96 | 6 | b0cea3f4e59635913d243612f2e8cf4c7b34e726 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.24e-06 | 196 | 96 | 6 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | (7)_Epithelial-B_(AT2)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.24e-06 | 196 | 96 | 6 | 345d4cc062b43bca9d506fbf23363469a9ba496f | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.36e-06 | 197 | 96 | 6 | bf10727fbe90b71d2ac60a11711e5f0701b3799d | |
| ToppCell | Biopsy_Other_PF-Epithelial-AT2|Biopsy_Other_PF / Sample group, Lineage and Cell type | 4.62e-06 | 199 | 96 | 6 | 9a65acfe9bf500db72142469cf17bf0973540001 | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-05 | 76 | 96 | 4 | 98271aadf026a01bf933f8279d11a0413e47d549 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.18e-05 | 168 | 96 | 5 | f3879a8e11eaf866f37c52e67021be43f0b8784a | |
| ToppCell | metastatic_Brain-B_lymphocytes-GrB-secreting_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 4.07e-05 | 177 | 96 | 5 | 43e1d0d3cf8f0c02e67d91f8dd1761df23d59e07 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.77e-05 | 183 | 96 | 5 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | droplet-Thymus-nan-18m-Myeloid-Plasma_cells_and_B_cells|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-05 | 183 | 96 | 5 | ffb1bbbccb34d1a7e99872611f497450039d5019 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-4|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 4.90e-05 | 184 | 96 | 5 | d9659d1e4465fec68f48a22edef443f354f6c7cf | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.90e-05 | 184 | 96 | 5 | 3261d767d5e3d9e9fbac22ad73ca14e44beed89c | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.03e-05 | 185 | 96 | 5 | 8207f9eff113eed429e961748c6b17d672a13b33 | |
| ToppCell | Control-T_cells-NK_cells|Control / group, cell type (main and fine annotations) | 5.03e-05 | 185 | 96 | 5 | 755c0998c729f462399f1d5e88adf4bfae31be30 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.16e-05 | 186 | 96 | 5 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 187 | 96 | 5 | f0c6e53035b00772377c4d5f761b4d11026b911a | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 187 | 96 | 5 | f20e7a1751694390f535ffb27b97e887220f8695 | |
| ToppCell | COPD-Epithelial-Mesothelial|COPD / Disease state, Lineage and Cell class | 5.56e-05 | 189 | 96 | 5 | 79bb2593ad5d17f94b17972884241f03a0f43770 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-05 | 189 | 96 | 5 | 6d24414ac6bd4f03f7a5ad3a6eba51d549a7b112 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.56e-05 | 189 | 96 | 5 | 37ecbd73408d462b47d7e5611f203143e08a2689 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.70e-05 | 190 | 96 | 5 | f573fef3762a30c38cf8fa7f45df0ffbb49dc873 | |
| ToppCell | (7)_Epithelial-D_(AT2)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.70e-05 | 190 | 96 | 5 | 832d6d3ad14665e50623afe1b8586ccae1a97de5 | |
| ToppCell | (7)_Epithelial-E_(AT2)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.85e-05 | 191 | 96 | 5 | 0fc8d109d5c50957ceef5b8b8b818b0c598b1bbe | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.85e-05 | 191 | 96 | 5 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.99e-05 | 192 | 96 | 5 | 30cefa0990ba1f379f350bfbf994a78db145075e | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 5.99e-05 | 192 | 96 | 5 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | COPD-Epithelial|COPD / Disease state, Lineage and Cell class | 5.99e-05 | 192 | 96 | 5 | 0644fad5df18f0021f6f49cca996d8cf47f972ff | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 5.99e-05 | 192 | 96 | 5 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.99e-05 | 192 | 96 | 5 | 0dc1f46e40346ed0b286e53b106a812441575100 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.14e-05 | 193 | 96 | 5 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.14e-05 | 193 | 96 | 5 | 8646e573f2d2ff175f3d02bfdf214e65f3b614d3 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-TRGV2_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.14e-05 | 193 | 96 | 5 | 544de0988510cc57744710d7cafe07aa27a0b99d | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)|Adult / Lineage, Cell type, age group and donor | 6.14e-05 | 193 | 96 | 5 | 31c0978ba78c9516d498aec0798902e57555e557 | |
| ToppCell | Immune-interstitial_macrophage_(C1Q_positive)|World / Lineage, Cell type, age group and donor | 6.14e-05 | 193 | 96 | 5 | 64d598162a256ac6c9f8280c8a9133661dfbb10f | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 6.14e-05 | 193 | 96 | 5 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-keratinocyte|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 193 | 96 | 5 | 33437fdb417d78463caee14a9f0e094da1733829 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.14e-05 | 193 | 96 | 5 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | Mesenchymal_cells-Endosteal_fibro.|Mesenchymal_cells / Lineage and Cell class | 6.30e-05 | 194 | 96 | 5 | 9a4b5de4d1d8a0aa76fed7b36548ea628f3009cc | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.30e-05 | 194 | 96 | 5 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.30e-05 | 194 | 96 | 5 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D231|Adult / Lineage, Cell type, age group and donor | 6.30e-05 | 194 | 96 | 5 | 800d3d7a9e864d2d6a100a4e4af22f45d5790a8d | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.30e-05 | 194 | 96 | 5 | 663e7e7fe48157e808b4f1a0ea6ad41944e857a2 | |
| ToppCell | (7)_Epithelial_cells|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.30e-05 | 194 | 96 | 5 | 413e8b9f1e15be363a7f4a8f727af3eeb9e9a928 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.30e-05 | 194 | 96 | 5 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | AT2_cells-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 6.45e-05 | 195 | 96 | 5 | 0792c1e959e933b10ae987d821ff43020dfdabad | |
| ToppCell | 367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.45e-05 | 195 | 96 | 5 | 4008fa86b5166087a4b20f89ae07e1dfc87c855d | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.45e-05 | 195 | 96 | 5 | 6617abca0009ad3d8731f515f91ab275f9ea4c40 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.45e-05 | 195 | 96 | 5 | fc0ae145a2118df7cbbc9ac4ca9dc12d26c087c4 | |
| ToppCell | 343B|World / Donor, Lineage, Cell class and subclass (all cells) | 6.45e-05 | 195 | 96 | 5 | 2290911fde6efacfa38b985a2541322968bee42d | |
| ToppCell | (3)_MNP-(3)_Macrophage_MARCOneg|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.45e-05 | 195 | 96 | 5 | e4b5e4b8832669fb4d1661ecd828b81e621d35c4 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.45e-05 | 195 | 96 | 5 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.61e-05 | 196 | 96 | 5 | 82b117be41f2e7d677a42d2a5198726eeccb16d0 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.61e-05 | 196 | 96 | 5 | b1abecc0aafc09ca70a5fde624f2a998c4aa3341 | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.61e-05 | 196 | 96 | 5 | a7cbe66ebd8931ef2b8ff26a42afce0ad1c48f17 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.61e-05 | 196 | 96 | 5 | 83aeb96a33802949238d8a097086a1812201d1b5 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.61e-05 | 196 | 96 | 5 | 65e161fd672e37a5d10f28011bb422c4d7042d6a | |
| ToppCell | ASK440-Epithelial-Type_2|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.77e-05 | 197 | 96 | 5 | 08d5bbeb77a4152af1c783bc958afcae24667767 | |
| ToppCell | distal-Epithelial-Alveolar_Epithelial_Type_2-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.93e-05 | 198 | 96 | 5 | 19eefd05573fbaed654af52bf0f8a26092b8b229 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.93e-05 | 198 | 96 | 5 | 5a85c286f79cde5811d2595a3397c6fb7685adee | |
| ToppCell | AT2_cells|World / lung cells shred on cell class, cell subclass, sample id | 6.93e-05 | 198 | 96 | 5 | 92c569c3b8a9fca2d4682cbf77ee8149bcc0a80a | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.93e-05 | 198 | 96 | 5 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | distal-Epithelial-Alveolar_Epithelial_Type_2-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.93e-05 | 198 | 96 | 5 | de5748c2b66ecc432974cf095ecd241369579f7c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.93e-05 | 198 | 96 | 5 | 641e7be258303bb9782d19fcf8693f317581d3b8 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_macrophage|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.10e-05 | 199 | 96 | 5 | b827dd8a249f904a0ff930a6c4d3b00fb7bc6fb1 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.10e-05 | 199 | 96 | 5 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.10e-05 | 199 | 96 | 5 | 15f7814b7074170eee7ccacaa670b1d128fc68bb | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.10e-05 | 199 | 96 | 5 | a38a981cffa61c8444a980916de7414e689a1b63 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.10e-05 | 199 | 96 | 5 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Transitional_AT2|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 7.10e-05 | 199 | 96 | 5 | e04a57a55c724091db353e2b3baf84372d788728 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_alveolar-AT2|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.10e-05 | 199 | 96 | 5 | fa5ddba3ac1ebe712cd4cdc3f20339f7c715d039 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_macrophage-macrophage|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.10e-05 | 199 | 96 | 5 | c0dcdda30485bb920d3706dcfb06f11b76b6ea37 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.10e-05 | 199 | 96 | 5 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.27e-05 | 200 | 96 | 5 | c2bde99b3bc7a8740441c1a0c1394892b940b857 | |
| ToppCell | cellseq-Epithelial|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.27e-05 | 200 | 96 | 5 | e4204c4b864346f47d76b0f0faae96f04fed5082 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.27e-05 | 200 | 96 | 5 | 65c83a3f6ee2a10bcb5b95076696232c6373a7b4 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.27e-05 | 200 | 96 | 5 | 40e969883bc302e8fbc6b6ab9814529dc1472902 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.27e-05 | 200 | 96 | 5 | 3ff9abd5e07780a59d5571da906fa15f00a1d5c2 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-AT2-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 7.27e-05 | 200 | 96 | 5 | ad9cdc82a647d379abc713a56db0e11bb6494106 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.27e-05 | 200 | 96 | 5 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.27e-05 | 200 | 96 | 5 | 8a8f9d9e5ffab3f736c4bd0a5bb616d442d137d1 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar-AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.27e-05 | 200 | 96 | 5 | b535323e18d9fb0dde1e0026df142c831e48c29f | |
| ToppCell | severe-CD163+_Monocytes_(Sample_ID1_d7)|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.27e-05 | 200 | 96 | 5 | a3f22826f3d8f917ff0594bdadd93b60763bcaa2 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 7.27e-05 | 200 | 96 | 5 | 9970e9bde6aa2ff3aef60dcb065ff15b7463e147 | |
| ToppCell | ASK440-Epithelial|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.27e-05 | 200 | 96 | 5 | cb617e2a0ca82b470b473b8d5906bc8879c85718 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Tshz2-Excitatory_Neuron.Slc17a7-Slc17a6.Tshz2-Npnt_(Retrosplenial_areas,_layer_5,_Npnt+)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.46e-05 | 41 | 96 | 3 | b1e70962de91a747ec718a3fad4247fd0cb7d9a8 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Tshz2-Excitatory_Neuron.Slc17a7-Slc17a6.Tshz2-Npnt_(Retrosplenial_areas,_layer_5,_Npnt+)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.46e-05 | 41 | 96 | 3 | 16dbb13baa47c4db80ddd83ac36aad6c43b5461a | |
| ToppCell | COVID-19-kidney-Epithelial_Doublet|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.80e-04 | 130 | 96 | 4 | 1ff28e9d3dc9a791e07d815f8fbb48f75d3f275b | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-04 | 137 | 96 | 4 | 587a369b148bb2600c06db39298feddfc99cb6ad | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-04 | 142 | 96 | 4 | 6469cf82552b39f63e20b841c9eed50de6f58d54 | |
| ToppCell | droplet-Liver-Npc-21m-Epithelial-Hepatocyte_(Midlobular)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-04 | 143 | 96 | 4 | 0cd332c128710291a39957d3da22953352f5c382 | |
| ToppCell | droplet-Liver-Npc-21m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-04 | 146 | 96 | 4 | 24e63124116b9a6796ae0495fc69dc6b6af28c38 | |
| ToppCell | droplet-Liver-Npc-21m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-04 | 146 | 96 | 4 | ae43d418492177546b7f85afffb4287d40815f88 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-04 | 147 | 96 | 4 | 9bc4185920b2b0f1fd5c6e2ec5583b9cd49c2efd | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-04 | 147 | 96 | 4 | 9b0f87a6dd5224c2b06deafeae04a1b04e53eb75 | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.95e-04 | 148 | 96 | 4 | d61123f0c811287843d066b932b4a9ff09c07c5b | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.95e-04 | 148 | 96 | 4 | c8e93b87212f55774223caa385859c566fa1981f | |
| Computational | Neighborhood of EGFR | 1.14e-06 | 32 | 64 | 5 | GNF2_EGFR | |
| Computational | Neighborhood of TIMP2 | 7.25e-06 | 46 | 64 | 5 | GNF2_TIMP2 | |
| Computational | Neighborhood of KISS1 | 9.95e-06 | 49 | 64 | 5 | GNF2_KISS1 | |
| Computational | Neighborhood of IGFBP1 | 5.21e-05 | 35 | 64 | 4 | GNF2_IGFBP1 | |
| Computational | Neighborhood of MMP11 | 1.08e-04 | 42 | 64 | 4 | GNF2_MMP11 | |
| Computational | Neighborhood of CDKN1C | 5.32e-04 | 27 | 64 | 3 | GNF2_CDKN1C | |
| Drug | AC1L1IPV | 2.58e-08 | 43 | 96 | 6 | CID000004683 | |
| Drug | Rgd Peptide | 7.81e-07 | 239 | 96 | 9 | CID000104802 | |
| Drug | AC1L193Y | 8.11e-06 | 65 | 96 | 5 | CID000000380 | |
| Drug | 5'-deoxypyridoxal | 1.55e-05 | 12 | 96 | 3 | CID000164889 | |
| Drug | phenyltriethoxysilane | 1.76e-05 | 2 | 96 | 2 | CID000013075 | |
| Drug | G-3SH | 1.76e-05 | 2 | 96 | 2 | CID000174237 | |
| Drug | iodoacetyldiethylstilbestrol | 1.76e-05 | 2 | 96 | 2 | CID006455327 | |
| Drug | methylmercuric bromide | 1.76e-05 | 2 | 96 | 2 | CID000068175 | |
| Drug | 5-methylisophthalate | 1.76e-05 | 2 | 96 | 2 | CID000068137 | |
| Drug | x 1 s | 1.76e-05 | 2 | 96 | 2 | CID000409694 | |
| Drug | Erlotinib Hydrochloride | 3.19e-05 | 86 | 96 | 5 | ctd:D000069347 | |
| Drug | dicyclohexyl phthalate | SORT1 FOXO3 EPRS1 PTPRB PNLIPRP2 ITLN1 ABCC5 ALS2 APOB FGFR4 NR3C1 BECN1 LGI1 | 4.86e-05 | 836 | 96 | 13 | ctd:C036042 |
| Drug | lenthionine | 5.26e-05 | 3 | 96 | 2 | CID000067521 | |
| Drug | mildiomycin | 5.26e-05 | 3 | 96 | 2 | CID000125665 | |
| Drug | methoxyethylmercury | 5.26e-05 | 3 | 96 | 2 | CID000115155 | |
| Drug | 4-methylumbelliferyl laurate | 5.26e-05 | 3 | 96 | 2 | CID000600674 | |
| Drug | methylmercuric iodide | 5.26e-05 | 3 | 96 | 2 | CID000067347 | |
| Drug | oxalylglycine | 7.99e-05 | 54 | 96 | 4 | CID003080614 | |
| Drug | methyl benzoquate | 1.05e-04 | 4 | 96 | 2 | CID000026383 | |
| Drug | Lidocaine | 1.05e-04 | 4 | 96 | 2 | DB00281 | |
| Drug | pentenoic acid | 1.05e-04 | 4 | 96 | 2 | CID000012299 | |
| Drug | alpha-ketoglutaramate | 1.05e-04 | 4 | 96 | 2 | CID000000048 | |
| Drug | ureidoglycine | 1.05e-04 | 4 | 96 | 2 | CID000439649 | |
| Drug | Ivin | 1.05e-04 | 4 | 96 | 2 | CID000014083 | |
| Drug | 8-BDB-TADP | 1.05e-04 | 4 | 96 | 2 | CID000130791 | |
| Drug | cadina-3,9-diene | 1.05e-04 | 4 | 96 | 2 | CID000010657 | |
| Drug | AC1L9CUQ | 1.05e-04 | 4 | 96 | 2 | CID000442451 | |
| Drug | luxabendazole | 1.05e-04 | 4 | 96 | 2 | CID000072019 | |
| Drug | N-butylmaleimide | 1.05e-04 | 4 | 96 | 2 | CID000239780 | |
| Drug | alpha-methylglutamate | 1.05e-04 | 4 | 96 | 2 | CID000095440 | |
| Drug | 2b E2 | 1.05e-04 | 4 | 96 | 2 | CID005327076 | |
| Drug | 1,2-cyclohexanedione | 1.06e-04 | 58 | 96 | 4 | CID000013006 | |
| Drug | thapsigargin; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.12e-04 | 179 | 96 | 6 | 7103_DN | |
| Disease | cD177 antigen measurement | 2.31e-09 | 18 | 93 | 5 | EFO_0021866 | |
| Disease | fascioliasis (biomarker_via_orthology) | 2.94e-05 | 3 | 93 | 2 | DOID:885 (biomarker_via_orthology) | |
| Disease | N,N-dimethylalanine measurement | 5.87e-05 | 4 | 93 | 2 | EFO_0800098 | |
| Disease | Cranioectodermal dysplasia | 5.87e-05 | 4 | 93 | 2 | cv:C4551571 | |
| Disease | CRANIOECTODERMAL DYSPLASIA 1 | 9.77e-05 | 5 | 93 | 2 | C0432235 | |
| Disease | childhood absence epilepsy (biomarker_via_orthology) | 1.46e-04 | 6 | 93 | 2 | DOID:1825 (biomarker_via_orthology) | |
| Disease | familial combined hyperlipidemia (is_marker_for) | 1.46e-04 | 6 | 93 | 2 | DOID:13809 (is_marker_for) | |
| Disease | Parkinsonism (biomarker_via_orthology) | 1.69e-04 | 34 | 93 | 3 | DOID:0080855 (biomarker_via_orthology) | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 2.01e-04 | 169 | 93 | 5 | DOID:3908 (is_marker_for) | |
| Disease | pregnancy-specific beta-1-glycoprotein 3 measurement | 2.04e-04 | 7 | 93 | 2 | EFO_0801906 | |
| Disease | hypoglycemia (is_implicated_in) | 2.72e-04 | 8 | 93 | 2 | DOID:9993 (is_implicated_in) | |
| Disease | Mesothelioma | 2.96e-04 | 41 | 93 | 3 | C0025500 | |
| Disease | brain ischemia (biomarker_via_orthology) | 3.10e-04 | 102 | 93 | 4 | DOID:2316 (biomarker_via_orthology) | |
| Disease | retinal nerve fibre layer thickness measurement | 3.41e-04 | 43 | 93 | 3 | EFO_0600004 | |
| Disease | Shortened QT interval | 5.31e-04 | 11 | 93 | 2 | C0151879 | |
| Disease | Small cell carcinoma of lung | 6.69e-04 | 54 | 93 | 3 | C0149925 | |
| Disease | visual perception measurement | 7.14e-04 | 223 | 93 | 5 | EFO_0009700 | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 7.49e-04 | 13 | 93 | 2 | C1846647 | |
| Disease | Psychosis, Brief Reactive | 8.72e-04 | 14 | 93 | 2 | C0033958 | |
| Disease | Schizophreniform Disorders | 8.72e-04 | 14 | 93 | 2 | C0036358 | |
| Disease | retinal layer thickness measurement | 9.11e-04 | 60 | 93 | 3 | EFO_0600002 | |
| Disease | hepatic encephalopathy (biomarker_via_orthology) | 1.00e-03 | 15 | 93 | 2 | DOID:13413 (biomarker_via_orthology) | |
| Disease | X-17654 measurement | 1.00e-03 | 15 | 93 | 2 | EFO_0800784 | |
| Disease | asthma, response to diisocyanate | 1.44e-03 | 261 | 93 | 5 | EFO_0006995, MONDO_0004979 | |
| Disease | ischemia (biomarker_via_orthology) | 1.45e-03 | 18 | 93 | 2 | DOID:326 (biomarker_via_orthology) | |
| Disease | Atrial Fibrillation | 1.67e-03 | 160 | 93 | 4 | C0004238 | |
| Disease | brain connectivity measurement | 1.69e-03 | 400 | 93 | 6 | EFO_0005210 | |
| Disease | Brugada Syndrome (disorder) | 2.59e-03 | 24 | 93 | 2 | C1142166 | |
| Disease | visual epilepsy (biomarker_via_orthology) | 2.92e-03 | 90 | 93 | 3 | DOID:11832 (biomarker_via_orthology) | |
| Disease | blood rubidium measurement | 3.04e-03 | 26 | 93 | 2 | EFO_0021529 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NYGLTFTQKWNTDNT | 66 | Q9Y277 | |
| AQYWSSGFTVLQASI | 166 | Q8WWZ7 | |
| DQGVSSNSSYLKWNK | 96 | Q6L9W6 | |
| AKSQVYSWGSNTFGQ | 576 | Q96Q42 | |
| TSLLSNYWFVGTQKV | 31 | Q2KHT4 | |
| GNSIGLSYQSAWLTV | 336 | P22455 | |
| KSGSVANNWIEIYNF | 51 | P58335 | |
| QNTSDYTSVGLQWFT | 1911 | Q8IYW2 | |
| GCSTNTKWFGQRNKY | 426 | Q8IYT2 | |
| LTFGSWTYNGNQVDI | 171 | Q9UGM1 | |
| ATWTSEYSINNTGKA | 1016 | O60706 | |
| QNGRSAKSEYQWITS | 311 | Q5JTW2 | |
| WLKTGQFFLSSVTYN | 101 | Q8TDJ6 | |
| GYNWNQSVLFQSSSK | 1216 | Q5TGY3 | |
| SSNETQWKELTQYFG | 121 | Q9H8W3 | |
| IQSVSSWKHGSGTQY | 351 | Q96B23 | |
| KVVYSASGSKINAWN | 971 | Q149M9 | |
| TQGDYINLQTKSSSW | 186 | O14966 | |
| WNAKSVYVVGNATAS | 91 | P10746 | |
| LNNYTKFQIATWGSL | 41 | Q15800 | |
| FKNSDGSYSVFWQQS | 831 | Q6IE37 | |
| GSYSVFWQQSQKGSI | 836 | Q6IE37 | |
| RSYQFNVKTVSGDSW | 1326 | P23467 | |
| QSDAQSPAVTWYKNG | 181 | O95256 | |
| VGDRWSSQQGSKAVY | 96 | Q8WWA0 | |
| VADWGQKVSFYQLSG | 256 | Q9HBG6 | |
| FSWGNYINSNSFIAA | 141 | Q05BQ5 | |
| NGGITITVNFWYKGA | 286 | Q9NWT6 | |
| AWYQTKFETLQAQAG | 281 | P08729 | |
| GSYSIKTQFNSEEQW | 411 | Q14457 | |
| NVTGWLNYTKQNPAT | 941 | Q92614 | |
| SQTAVENYGSWGQSF | 206 | Q9BY49 | |
| EVYSGKTNSNAITSW | 131 | Q99550 | |
| GNSSQNWQRFYQLTK | 706 | P04150 | |
| GNFLQWYGIFSNKTL | 781 | Q9Y5B6 | |
| YWFGLSNSVVKVNGK | 206 | Q5VYS4 | |
| YTFWLTASTSVGNGN | 1066 | Q9UMZ3 | |
| NAGYGNASNWISTKT | 1561 | Q9UMZ3 | |
| YETSVGTFWSNNNGT | 211 | Q16821 | |
| GTFWSNNNGTNYTFI | 216 | Q16821 | |
| QQEILTKSGAWFYNS | 171 | Q9UQ26 | |
| TNYLQNGQFSRWKDT | 666 | Q3MJ16 | |
| SYWIKQGSGNTTVTR | 881 | O15440 | |
| FGQSGLFVQTWYANS | 326 | Q9Y2L6 | |
| WFVGTVNTNTSYKAF | 76 | Q1HG44 | |
| YANTINWKKLFGTSG | 471 | P00533 | |
| QKAASGTTGTYQEWK | 4131 | P04114 | |
| GTSTWQFNFKFNLTE | 91 | Q9UIV1 | |
| EGNTYNSSFKWQSPA | 111 | Q8N8U9 | |
| GWLYKGNFNSTVNNT | 186 | Q96BY6 | |
| NEKAWFQTPYTTFGQ | 466 | Q9Y232 | |
| NKSYTLNGTKTWITN | 201 | Q92947 | |
| NAGGVTVSYFEWLKN | 431 | P00367 | |
| ASEYTWNTKTGRGQF | 571 | P20794 | |
| WNTKTGRGQFSGRTY | 576 | P20794 | |
| FVFNSVKNGSTWTYG | 76 | P60893 | |
| WSVGQVSTNTSYKAF | 76 | Q1HG43 | |
| YSWTINGKFQLSGQK | 271 | Q9UQ72 | |
| NAGGVTVSYFEWLKN | 431 | P49448 | |
| LNTGESGNFTSWRYK | 346 | P54317 | |
| WGDKSYNLISFSNGV | 306 | Q9UKG9 | |
| GWGDFYSNIKTVALN | 101 | O95157 | |
| WYSGETCNQGTQKSL | 4376 | Q685J3 | |
| NSTAVISWTYALGKQ | 191 | Q8TC99 | |
| VGNFTGAKQASSQSW | 656 | O43524 | |
| LKFNVLQNWGTFYGS | 291 | Q92521 | |
| WGSDNTIFFTTYANG | 261 | Q99523 | |
| QFASSQETYGKSPFW | 36 | Q7Z4G4 | |
| QFAYQNSWGLTTRTI | 1266 | P07814 | |
| RGFQWVTGDNNTSYS | 106 | P07204 | |
| TWKSAIYGFGDQSNL | 196 | Q8NBX0 | |
| AEYSWTINGKFQLSG | 361 | Q00889 | |
| GSFTVLDNSAWYQKQ | 166 | Q9Y2Z4 | |
| ESTNGFTYKPQGTQW | 1851 | Q9NTG1 | |
| PAQYSWTINGKFQLS | 361 | Q9UQ74 | |
| AANSGYSWLITKGRN | 286 | Q9NQW5 | |
| LGQYTSQGSVTAWRK | 96 | P48065 | |
| NGYTVTNGWKIHNTA | 351 | Q8TCU6 | |
| QWFIGKSTSSGQVGF | 306 | Q8TF17 | |
| SSTIQRFYKNEGGTW | 271 | Q13228 | |
| KNGGYIWIQSSATIA | 401 | Q8IXF0 | |
| WQKTSGNYLAVTGAD | 21 | Q8NEZ3 | |
| VEQQYGWSASKTNFL | 316 | G3V0H7 | |
| PAQYSWTINGKFQLS | 361 | Q13046 | |
| TGTLKYQAWDASQGQ | 531 | Q9NP91 | |
| VDGLATSWVNSSNYK | 51 | Q7Z460 | |
| TVTSNGQIFGNWTFG | 991 | P98196 | |
| QYTSSWGAQILSSGK | 326 | I1YAP6 | |
| KPQTNKSAYNSYSWG | 1071 | Q14157 | |
| GSYQRFGQSNSTTWF | 36 | Q7Z2H8 | |
| NSTGSFFWVNVKVNF | 1336 | Q9Y5Y9 | |
| NRITVTWGNYGKSYS | 256 | Q8N2W9 | |
| WSTYTKAQQGESNRG | 61 | O14668 | |
| YGTQGNVGLTNAWSI | 126 | O14817 | |
| GSFTWLGQTQYKLQL | 1366 | Q9Y2L5 | |
| SNWSLSKTEYAQGQG | 811 | Q8NEE8 | |
| YSWTINGKFQQSGQN | 271 | P11465 | |
| KWGGVTVQVNSAFFT | 461 | Q5T9L3 | |
| YFWTINGKFQQSGQK | 271 | Q15238 | |
| KSSVRSTNNWNYSGP | 226 | Q9H2Y7 | |
| SSKAGFTTIYKWNGN | 351 | O95970 | |
| FTKQWYLINTGQADG | 126 | P16519 |